Enioutina Elena Yu, Teng Lida, Fateeva Tatyana V, Brown Jessica C S, Job Kathleen M, Bortnikova Valentina V, Krepkova Lubov V, Gubarev Michael I, Sherwin Catherine M T
a Division of Clinical Pharmacology, the Department of Pediatrics, School of Medicine , University of Utah , Salt Lake City , UT , USA.
b Department of Pathology, School of Medicine , University of Utah , Salt Lake City , UT , USA.
Expert Rev Clin Pharmacol. 2017 Nov;10(11):1203-1214. doi: 10.1080/17512433.2017.1371591. Epub 2017 Aug 31.
In the modern antimicrobial era, the rapid spread of resistance to antibiotics and introduction of new and mutating viruses is a global concern. Combating antimicrobial resistant microbes (AMR) requires coordinated international efforts that incorporate new conventional antibiotic development as well as development of alternative drugs with antimicrobial activity, management of existing antimicrobials, and rapid detection of AMR pathogens. Areas covered: This manuscript discusses some conventional strategies to control microbial resistance. The main purpose of the manuscript is to present information on specific herbal medicines that may serve as good treatment alternatives to conventional antimicrobials for infections sensitive to conventional as well as resistant strains of microorganisms. Expert commentary: Identification of potential new antimicrobials is challenging; however, one source for potential structurally diverse and complex antimicrobials are natural products. Natural products may have advantages over other post-germ theory antimicrobials. Many antimicrobial herbal medicines possess simultaneous antibacterial, antifungal, antiprotozoal and/or antiviral properties. Herbal products have the potential to boost host resistance to infections, particularly in immunocompromised patients. Antimicrobial broad-spectrum activity in conjunction with immunostimulatory properties may help to prevent microbial resistance to herbal medicine. As part of the efforts to broaden use of herbal medicines to treat microbial infections, pre-clinical and clinical testing guidelines of these compounds as a whole should be implemented to ensure consistency in formulation, efficacy and safety.
在现代抗菌时代,抗生素耐药性的迅速传播以及新型和变异病毒的出现是全球关注的问题。对抗抗菌药物耐药微生物(AMR)需要国际社会的协调努力,包括开发新的传统抗生素以及具有抗菌活性的替代药物、管理现有抗菌药物以及快速检测AMR病原体。涵盖领域:本手稿讨论了一些控制微生物耐药性的传统策略。该手稿的主要目的是介绍特定草药的信息,这些草药可作为对传统微生物敏感菌株以及耐药菌株感染的传统抗菌药物的良好治疗替代品。专家评论:鉴定潜在的新型抗菌药物具有挑战性;然而,潜在的结构多样且复杂的抗菌药物的一个来源是天然产物。天然产物可能比其他后细菌理论抗菌药物具有优势。许多抗菌草药同时具有抗菌、抗真菌、抗原虫和/或抗病毒特性。草药产品有可能增强宿主对感染的抵抗力,特别是在免疫功能低下的患者中。抗菌广谱活性与免疫刺激特性相结合可能有助于防止微生物对草药产生耐药性。作为扩大草药用于治疗微生物感染的努力的一部分,应实施这些化合物的整体临床前和临床试验指南,以确保制剂、疗效和安全性的一致性。